Why the study?
The optimal surgical strategy for severe rheumatic mitral stenosis with more than mild regurgitation remains unclear.
Does mitral valve repair improve survival compared to replacement in patients with severe rheumatic mitral stenosis and more than mild regurgitation?
Does mitral valve repair improve survival compared to replacement in patients with severe rheumatic mitral stenosis and more than mild regurgitation?
In patients with severe rheumatic mitral stenosis and more than mild regurgitation, mitral valve repair is associated with improved 5-year survival compared to replacement without increasing the risk of reoperation.
Supports repair over replacement when feasible in rheumatic MS with MR; extends observational evidence of superior 5-year survival.
OBJECTIVE The optimal surgical strategy for severe rheumatic mitral stenosis with more than mild regurgitation remains unclear. We aimed to characterize mitral valve pathology in these patients and compare outcomes between repair and replacement. METHODS This dual-center retrospective study analyzed 870 surgically-treated severe rheumatic mitral stenosis patients with complete imaging. Inverse probability weighting balanced baseline characteristics (SMD<0.1). Quantitative assessment combined echocardiography and computed tomography angiography. Primary endpoint was all-cause mortality. RESULTS Of 870 patients, 408 (46.9%) had more than mild regurgitation. Compared to pure stenosis, these patients had larger left atrial diameters (51.0 vs 49.0 mm, P<0.001), higher mean pulmonary artery pressures (42.0 vs 41.0 mmHg, P=0.015), and shorter anterior (33.3 vs 33.7 mm, P=0.026) and posterior (19.2 vs 20.0 mm, P<0.001) leaflets, and a comparable rate of mitral valve repair (65.0% vs 63.0%, P=0.595). Among patients with more than mild regurgitation, early outcomes did not differ between repair (n=265) and replacement (n=143). At 5-year postoperative follow-up, repair was associated with significantly lower mortality (1.4% vs. 7.1%, P=0.009) and comparable reoperation rates (1.4% vs. 1.0%, P=1.000). Survival analysis favored repair (log-rank P=0.005), which independently predicted survival (HR 0.347; P=0.039). CONCLUSIONS Nearly half of severe rheumatic mitral stenosis patients present with more than mild regurgitation. Mitral repair demonstrates improved 5-year survival without increased reoperations, supporting its consideration as a key candidate strategy when feasible.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: